Department of Preventive Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumi-cho, Showa-ku, Nagoya 466-8550, Japan.
J Clin Biochem Nutr. 2013 Jul;53(1):15-20. doi: 10.3164/jcbn.13-17. Epub 2013 Jun 1.
Chronic kidney disease (CKD) is well known as a strong risk factor for both of end-stage renal disease and cardiovascular disease. To clarify the association of polymorphisms in the genes encoding antioxidant enzymes (SOD2, CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) with the risk of CKD in Japanese, we examined this association using the cross-sectional data of Japan Multi-Institutional Collaborative Cohort (J-MICC) Study. The subjects were 3,285 men and women, aged 35-69 years, selected from J-MICC Study participants for whom genotyping were conducted by multiplex polymerase chain reaction-based Invader assay. The prevalence of CKD was determined for CKD stages 3-5 (eGFR <60 ml/min/1.73 m(2)). When those with CAT C-262T C/C were defined as reference, those with CAT C-262T C/T demonstrated the OR for CKD of 0.67 (95% CI 0.43-1.06) with the marginally significant trend for decreased odds ratio with increasing numbers of T allele (p = 0.070). There were no significant associations between the other polymorphisms with CKD risk. The present study found a marginally significant trend of the decreased risk of CKD with increasing numbers of T allele of CAT, which may suggest the possibility of personalized risk estimation of this life-limiting disease in the near future.
慢性肾脏病(CKD)是终末期肾病和心血管疾病的强烈危险因素。为了阐明编码抗氧化酶(SOD2、CAT、GPx、TXNRD、SEPP1、SEP15 和 SELS)的基因多态性与日本 CKD 风险之间的关联,我们使用日本多机构合作队列(J-MICC)研究的横断面数据进行了这项研究。研究对象为年龄在 35-69 岁的 3285 名男性和女性,他们从 J-MICC 研究参与者中选择出来,这些参与者的基因分型通过多重聚合酶链反应基于 Invader 检测法进行。根据 eGFR<60ml/min/1.73m2,确定了 CKD 分期 3-5 期的 CKD 患病率。当将 CAT C-262T C/C 定义为参考时,CAT C-262T C/T 表现出 CKD 的 OR 为 0.67(95%CI 0.43-1.06),并且随着 T 等位基因数量的增加,优势比呈下降趋势,具有边缘显著意义(p=0.070)。其他多态性与 CKD 风险之间没有显著关联。本研究发现 CAT 中 T 等位基因数量的增加与 CKD 风险的降低呈边缘显著趋势,这可能表明在不久的将来对这种限制生命的疾病进行个体化风险估计的可能性。